Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
REGULATORY Govt’s Honebuto Draft Confirms FY2027 Off-Year Drug Price Revision
July 1, 2026
-
ACADEMIA NEJM Retracts Paper on Tavneos’ Pivotal Study
July 1, 2026
-
REGULATORY Govt Presents Growth Strategy Draft Ahead of July Approval
July 1, 2026
-
BUSINESS Ultragenyx Seeks Japan Approval for GSDIa Gene Therapy
July 1, 2026
-
COMMENTARY New Generic Listings Plunge, Industry Heads for a Shakeout
July 1, 2026
-
BUSINESS Specialist Hails Wegovy as “Game Changer” for MASH Treatment
July 1, 2026
-
REGULATORY Japan Moves to Add Ceftriaxone to Economic Security List
July 1, 2026
-
REGULATORY LDP Group Submits Honebuto Proposal, Urges Pediatric Cancer Platform
July 1, 2026
-
BUSINESS Alfresa Boosts Stake in ENT Cell Sheet Startup
July 1, 2026
-
BUSINESS Eisai, UCL Renew Neuroscience Alliance to 2030
July 1, 2026
-
BUSINESS Asahi Kasei Nabs Japan Rights to Additional Empaveli Indications
July 1, 2026
-
BUSINESS Viatris Eyes Japan Filing This Year for IgAN Drug
July 1, 2026
-
REGULATORY Lower House Clears Immunization Act Revision
July 1, 2026
-
REGULATORY LDP Cautious over Ishin’s GDP-Linked Healthcare Spending Proposal
July 1, 2026
-
BUSINESS Expert Calls for Greater Awareness of LC-FAOD after Dojolvi Debut
June 30, 2026
-
REGULATORY Japan Begins Review of Domestic CGT Seeds with Limited Market Potential
June 30, 2026
-
ORGANIZATION Incubator Led by Ex-Chugai CEO to Seek Govt Support, Raise Private Funds
June 30, 2026
-
REGULATORY Govt Panel Urges 2027 Bill to Expand Secondary Use of Health Data
June 30, 2026
-
BUSINESS Toho Defense Measure Scraped through Shareholder Vote: Report
June 30, 2026
-
BUSINESS Enhertu Snags EU Approval in HER2 Positive Solid Tumors
June 30, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…